Welcome to our dedicated page for ParkerVision news (Ticker: $PRKR), a resource for investors and traders seeking the latest updates and insights on ParkerVision stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ParkerVision's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ParkerVision's position in the market.
ParkerVision (OTCQB:PRKR), a developer of wireless communication technologies, reported a net loss of $0.7 million for Q1 2024, or $0.01 per share, contrasting with Q1 2023's net income of $13.1 million due to a $25 million patent settlement. Cash used in operations was $0.8 million, leaving the company with $1.7 million in cash. Key developments include awaiting a U.S. Court of Appeals decision on their case against Qualcomm and favorable claim rulings in patent cases against MediaTek and Realtek, with trials set for late 2024 and early 2025. Additionally, cases against various companies, including Qualcomm and Apple, remain stayed pending other outcomes.